Seasoned investor and operator with cross-border experience in growth-stage technology and healthcare companies. Malgorzata Serafin has led strategy, corporate development and M&A initiatives and worked with buyouts, minority growth investments and operational turnarounds. She brings a finance-oriented approach to portfolio value creation, board-level governance and exit planning, and typically engages with founders, PE sponsors and corporate acquirers.
Seasoned investor and operator with cross-border experience in growth-stage technology and healthcare companies. Malgorzata Serafin has led strategy, corporate development and M&A initiatives and worked with buyouts, minority growth investments and operational turnarounds. She brings a finance-oriented approach to portfolio value creation, board-level governance and exit planning, and typically engages with founders, PE sponsors and corporate acquirers.
Combines a finance-driven, operational lens to back growth-stage technology and healthcare companies across borders, prioritizing investments where strategic M&A, corporate development and governance can accelerate scale and exit value. Targets minority growth and control-oriented situations where board engagement, operational turnarounds and disciplined capital allocation unlock EBITDA improvement. Deploys medium-to-long horizon capital with rigorous due diligence, clear value-creation milestones and scenario-based risk sizing. Favors assets with strong founder alignment or sponsor partnerships, differentiated product-market fit and predictable regulatory pathways. Competitive edge lies in marrying dealcraft and execution—crafting integration plans, reinforcing commercial execution and shaping exit routes to capture multiple expansion.
Combines a finance-driven, operational lens to back growth-stage technology and healthcare companies across borders, prioritizing investments where strategic M&A, corporate development and governance can accelerate scale and exit value. Targets minority growth and control-oriented situations where board engagement, operational turnarounds and disciplined capital allocation unlock EBITDA improvement. Deploys medium-to-long horizon capital with rigorous due diligence, clear value-creation milestones and scenario-based risk sizing. Favors assets with strong founder alignment or sponsor partnerships, differentiated product-market fit and predictable regulatory pathways. Competitive edge lies in marrying dealcraft and execution—crafting integration plans, reinforcing commercial execution and shaping exit routes to capture multiple expansion.
| Trades 3517 | Longs Won 2276/3517 64% | Profit Factor 4.91 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.28M |
| Average Win $575,580.08 | Best Trade (Aug 14) $21.08M | Sharpe Ratio -46.88 |
| Average Loss -$215,115 | Worst Trade (Mar 31) -$6M | Z-Score -6.89 (100%) |
| Commissions $0 | Avg. Trade Length 1y 8m 1w 3d | Expectancy $296,577.35 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,623 | 5,960 | 5,298 | 4,636 | 3,974 | 3,311 | 2,649 | 1,987 | 1,325 | 662 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 4,000 | $463,420 | $553,480 | - | $90,060 | 19.43% | -0.245% |
AAPL Apple Inc. | 170,000 | $36.9M | $52.51M | - | $15.61M | 42.3% | -7.354% |
ABBV AbbVie Inc. | 21,200 | $3.95M | $5.32M | - | $1.37M | 34.74% | -2.513% |
ABNB Airbnb, Inc. | 11,000 | $1.34M | $1.67M | - | $331,100 | 24.79% | -0.368% |
ABT Abbott Laboratories | 21,000 | $2.85M | $2.22M | - | -$632,369.67 | -22.17% | +0.085% |
ADBE Adobe Inc. | 15,000 | $6.41M | $3.76M | - | -$2.66M | -41.41% | +1.013% |
ADI Analog Devices, Inc. | 17,000 | $4.15M | $6.25M | - | $2.1M | 50.51% | +0.202% |
ADM Archer-Daniels-Midland Co | 15,150 | $1.13M | $1.2M | - | $73,564.52 | 6.53% | -1.662% |
ADP Automatic Data Processing Inc. | 13,000 | $3.75M | $3.46M | - | -$287,410.01 | -7.66% | +0.982% |
ADSK Autodesk, Inc. | 7,000 | $2.08M | $1.64M | - | -$436,706.47 | -21.03% | -0.328% |
AEM Agnico Eagle Mines Limited | 203,120 | $15.74M | $29.51M | - | $13.76M | 87.41% | -3.635% |
AEP American Electric Power Company, Inc. | 17,000 | $2.33M | $2.17M | - | -$152,320 | -6.55% | +0.055% |
AG First Majestic Silver Corp | 243,706 | $2.74M | $3.66M | - | $920,927.59 | 33.59% | -4.207% |
AGI Alamos Gold Inc. | 198,363 | $3.71M | $5.52M | - | $1.81M | 48.75% | -2.007% |
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 5,000 | $2.42M | $1.56M | - | -$858,949.95 | -35.57% | +3.851% |
ALNY Alnylam Pharmaceuticals Inc | 7,500 | $2.96M | $1.54M | - | -$1.42M | -47.95% | +0.019% |
AMAT Applied Materials, Inc. | 26,000 | $4.83M | $13.2M | - | $8.36M | 173% | +1.176% |
AMD Advanced Micro Devices, Inc. | 53,000 | $6.25M | $25.24M | - | $18.98M | 303.66% | -1.904% |
AMGN Amgen Inc. | 16,400 | $4.59M | $6.32M | - | $1.73M | 37.64% | -0.64% |
AMZN Amazon.com Inc | 143,000 | $27.26M | $38.84M | - | $11.58M | 42.47% | +15.321% |